European Medicines Agency Strengthens Gilenya Guidelines While Review Underway
The European Medicines Agency, the agency responsible for the scientific evaluation of medicines for use in the European Union, has undertaken a review of Gilenya following cases of serious cardiac events and death in patients who had recently started ...
Read MoreAcute MS Now Covered Under SSDI “Compassionate Allowances”
As of December 2011, the Social Security Administration (SSA) now recognizes “malignant multiple sclerosis” – an acute form of MS – as a condition that qualifies for a “Compassionate Allowance&rdquo...
Read MoreInvestigation Underway into Death of Gilenya Patient
Novartis has confirmed that a person with MS died one day after taking the first dose of Gilenya; however, the exact cause of death has not been determined and it is too soon to know whether Gilenya played a role in the person’s death, repres...
Read MoreGenetic clue to MS identified
Another piece of evidence linking Vitamin D deficiency to MS has been reported by British and Canadian researchers who have pinpointed a rare genetic variant which causes reduced levels of vitamin D, OxfordUniversityresearchers along with Canadian col...
Read More